The performance of a colorimetric assay for nicotine metabolites to validate self-reported smoking classification (nonsmoker, ex-smoker, and smoker) was assessed in a group of diabetic patients (n = 201). comparison of the results with those of cotinine immunoassay (ELISA), by comparing respective areas under receiver operating characteristic curves, established the superiority of the cotinine immunoassay method. Adjusting the urinaryconcentrationsof nicotine metabolites for creatinine excretion significantlylowered test performance. The sensitivityand specificityfor the assay of nicotine metabolites to discriminate smoking classificationwithin the diabetic patients at a threshold of 28 jmoI/L "cotininecarboxylicacid equivalents" were 68.4% and 98.6%, respectively; the corresponding sensitivityand specificity for urinarycotinine at a cutoff of 0.5 tmol/L were 94.7% and 100%. The low sensitivity of the colorimetric urinary nicotine metabolites assay precludes its application as an objective assessment of smoking status in our patient population.
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There is strong evidence that smoking is a major independent risk factor for cardiovascular disease and mortality in diabetes (1), as well as being related to microvascular complications (2). Measurement of biochemical tobacco markers in prospective or epidemiological studies of diabetes meffitus should therefore provide several advantages, including confirmation of self-reported information and a quantitative estimate of the actual intake of cigarette smoke.
Although nicotine (see Fig. 1 ) is the major constituent of cigarette smoke, usually itsprincipal metabolite cotinine is measured in plasma or urine by either chromatographic or immunoassay techniques (3). A simple colorimetric assay, based on the Konig reaction of urinary nicotine metabolites, has also been described (4,5), with sensitivity and specificity similar to that for cotinine immunoassays (5, 6). The main purpose of this study was to assess the validity of the colorimetric assay quantifying urinary nicotine metabolites as a verification of the smoking status of diabetic patients, the majority of whom had coexisting medical disorders (hypertension, cardiovascular disease) and were taking a variety of medications. Colon metric assay of urinary nicotine metabolites. Cotinine carboxylic acid (CCA; Fig. 1 ), nicotine, cotinine, barbituricacid,and Chloramine-T were purchased from Sigma-Aldrich (Castle Hill, Australia).
MaterIals and Methods
The procedure used was essentially that reported by Peach et al. (4), except that CCA, rather than cotinine, was chosen as the calibration standard-being cheaper, available in stable crystalline form, and structurally closer to trans-3'-hydroxycotinine ( Fig. 1) , the main urinary metabolite of nicotine (7). In brief, the colorimetric method is as follows: Add 250 jL of urine, standard, or quality-control material, in duplicate, to a test tube, followed by 100 L of acetate buffer(4.0 molIL, pH 4.7) and allow the mixture to stand at room temperature for 15 min. Then in rapid succession, add 50 /LL of aqueous potassium cyanide (100 gIL), 50 tL of aqueous Chloramine-T (100 gIL), and 250 L of barbituric acid solution (10 gIL, in an equivolume mixture of water and ace- 
Results
differenceexistsbetween the categories for men and women-mainly a higher proportion of male ex-smokers.
Comparison of the sensitivities
and specificities of the urinary nicotine metabolites and cotinine assays, corrected and uncorrected for creatiine excretion, is based on the areas under the receiver operating characteristic (ROC) curves (9) and is summarized in Table 2 . The results establish that urinary cotinine determined by immunoassay is a significantly better discriminator of smoking status than is colorimetric estimation of nicotine metabolites, and that adjustment for creatinine excretion lowers diagnostic performance. Figure 2 shows the sensitivity, specificity, and efficiency over a continuum of cutoff values for nicotine Table 2 . ROC curve analysis for assays of cotinine and nicotine metabolites. All three false positives were from the ex-smokers group and each had a urinary cotinine concentration 5.68 zmol/L. The two negatives were one patient who had described herself as a "social" smoker (cotinine 0.17 molJL) and another (cotinine 0.18 pmolIL) who had been hospitalized for about a week when the urine specimen was taken.
Patients' particulars and analyte values are summarized in Table 1 . The relative proportion of patients in the three categories is similar to that recently reported for a larger sample (n = 3006) of people with diabetes (8). The data also indicate that current smokers are significantly younger than nonsmokers and ex-smokers, and that a t298 CLINICALCHEMISTRY, Voi.40, No.7, 1994 metabolites to discriminate corresponding urinary cotinine concentration of 0.5 moI/L in a larger sample (n = 252) that included subjects of unknown smoking status and for which the calculated smoking prevalence, based on a urinary cotinine 0.5 LmoIIL, was 17.9%. The area under the ROC curve was 0.9569 ± 0.017 for the urinary cotinine determination, compared with 0.8882 ± 0.033 (P = 0.026) for the nicotine metabolites/ creatinine ratio.
Discussion
In assay can "accurately evaluate smoking 8tatus." However, no performance characteristics for the three assays were provided.
In the present study, the sensitivity and specificity of the assay of urinary nicotine metabolites to characterize smoking status (cotinine 0.5 1nnol/L) in the diabetic subjects (Table 1) were 68.4% and 98.6%, respectively, at a threshold value of 28 pmoI/L. The sensitivity within our group of patients is therefore appreciably lower than previously found in healthy subjects (4-6). Unlike previous findings (5, 6), the cotinine immunoassay had significantly better performance to discriminate smoking status than did the colorimetric nicotine metabolites method (Table 2) . Furthermore, adjusting the concentration of the nicotine met.abolites for creatinine significantly decreased, rather than increased (4), assay performance ( Table 2) .
The colorimetric procedure, based on the Konig reaction, is not specific for nicotine or its metabolites but is a reaction common to most substituted pyridines. Furthermore, as stated above, the relative response, even among similar compounds (e.g., in Fig. 1) , is quite varied. Therefore, both intra-and interindividual variations in overall nicotine metabolism may significantly affect the concentrations of urinary nicotine metabolites. Similarly, when metabolic pathways are affected, e.g., by certain medical disorders and certain medications, the discriminatory thresholds established in healthy subjects to characterize smoking status may no longer be accurate. Validation of self .reported smoking is primarily aimed at assessing under-reporting (false negatives). Many studies, however, have found minimal misclassification in this direction, and the accuracy of self-reported status parallels that established by biochemical methods (11). The low sensitivity found in this study for the colorimetric assay of nicotine metabolites precludes its application as an objective measure of smoking status. We do not know the reasons for this low sensitivity, but it may be related to the pathophysiology of diabetes meffitus or to the medications used to treat diabetes and associated conditions.
